A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study. Επικοινωνία Submitted by Δημήτρης Σπάχος on Πέμ, 04/30/2015 - 11:26
